Swine Influenza
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Prophylaxis of A/H3N2v Influenza
Conditions
Prophylaxis of A/H3N2v Influenza
Trial Timeline
May 1, 2013 → Sep 1, 2014
NCT ID
NCT01855945About Swine Influenza
Swine Influenza is a phase 1 stage product being developed by Novartis for Prophylaxis of A/H3N2v Influenza. The current trial status is completed. This product is registered under clinical trial identifier NCT01855945. Target conditions include Prophylaxis of A/H3N2v Influenza.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01855945 | Phase 1 | Completed |
Competing Products
20 competing products in Prophylaxis of A/H3N2v Influenza